Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

BUY
$223.05 - $302.68 $347,958 - $472,180
1,560 New
1,560 $445,000
Q4 2022

Feb 13, 2023

SELL
$204.38 - $296.82 $633,986 - $920,735
-3,102 Reduced 66.4%
1,570 $322,000
Q3 2022

Nov 07, 2022

BUY
$195.21 - $310.53 $118,297 - $188,181
606 Added 14.9%
4,672 $1.3 Million
Q2 2022

Aug 08, 2022

SELL
$115.91 - $214.48 $41,727 - $77,212
-360 Reduced 8.13%
4,066 $777,000
Q1 2022

May 10, 2022

BUY
$127.96 - $207.36 $98,913 - $160,289
773 Added 21.16%
4,426 $918,000
Q4 2021

Feb 11, 2022

BUY
$165.13 - $241.83 $207,733 - $304,222
1,258 Added 52.53%
3,653 $651,000
Q3 2021

Oct 12, 2021

BUY
$163.99 - $235.57 $153,494 - $220,493
936 Added 64.15%
2,395 $493,000
Q2 2021

Aug 09, 2021

BUY
$131.45 - $201.49 $191,785 - $293,973
1,459 New
1,459 $277,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.